The Process of Incorporating Insulin Pumps into the Everyday Lives of People with Type 1 Diabetes: A Critical Interpretive Synthesis
Overview
Affiliations
Background: Insulin pump therapy (IPT) is a technological advancement that has been developed to help people manage Type 1 diabetes (T1D). However, ways of managing diabetes requiring the implementation of health technologies bring new complexities and a need to understand the factors which enable people with T1D to incorporate a novel device. This new comprehension could provide an exemplar for people with long-term conditions to incorporate new technologies more generally.
Objective: To determine what influences the incorporation, adaptation and use of IPT into the everyday lives of people living with diabetes.
Design: Critical interpretive synthesis (CIS) using systematic searches undertaken in 7 electronic databases of literature, published 2008 onwards.
Results: A total of 4998 titles were identified, 274 abstracts reviewed, 39 full articles retrieved and 22 papers selected for analysis. Three themes emerged which were of relevance to the introduction and use of IPT; Tensions between expectations and experiences in adoption and early adaptation; Negotiation of responsibility and accessing support; Reflexivity, active experimentation and feedback.
Conclusions: This CIS builds on earlier reviews on lived experiences of IPT. Novel insights are offered through examination of the experiences of pump users from children through to adults, their families and health-care professionals. Expectations of what the device can do to improve self-management impacts on the early stages of adoption as the reality of the technology requires substantial thought and action. Areas for intervention to improve IPT incorporation include establishing who is responsible for management tasks of the device and enabling navigation to further means of support and resources.
The Psychological Implications of Automated Insulin Delivery Systems in Type 1 Diabetes Care.
Nefs G Front Clin Diabetes Healthc. 2023; 3:846162.
PMID: 36992780 PMC: 10012062. DOI: 10.3389/fcdhc.2022.846162.
Lunati M, Morpurgo P, Rossi A, Gandolfi A, Cogliati I, Bolla A Front Endocrinol (Lausanne). 2022; 13:816599.
PMID: 35498423 PMC: 9048202. DOI: 10.3389/fendo.2022.816599.
Persson M, Leksell J, Ernersson A, Rosenqvist U, Hornsten A BMJ Open. 2022; 12(4):e057836.
PMID: 35365536 PMC: 8977750. DOI: 10.1136/bmjopen-2021-057836.
Couples Managing Type 1 Diabetes Using Diabetes Technology.
Allen N, Litchman M, Neller S, Tracy E, de Grey R, Grigorian E Diabetes Spectr. 2021; 34(4):378-387.
PMID: 34866871 PMC: 8603131. DOI: 10.2337/ds20-0045.
Barriers to Uptake of Insulin Technologies and Novel Solutions.
Pauley M, Berget C, Messer L, Forlenza G Med Devices (Auckl). 2021; 14():339-354.
PMID: 34803408 PMC: 8594891. DOI: 10.2147/MDER.S312858.